Publications in collaboration with researchers from Yale School of Medicine (20)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. MIF is a common genetic determinant of COVID-19 symptomatic infection and severity

    QJM : monthly journal of the Association of Physicians, Vol. 116, Núm. 3, pp. 205-212

2022

  1. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  2. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  5. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851

2021

  1. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552

  2. Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis

    Cell Metabolism, Vol. 33, Núm. 9, pp. 1820-1835.e9

2020

  1. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  2. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2014

  1. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    PLoS Genetics, Vol. 10, Núm. 4

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754

2007

  1. Hypoxia transduction by carotid body chemoreceptors in mice lacking dopamine D2 receptors

    Journal of Applied Physiology, Vol. 103, Núm. 4, pp. 1269-1275

2003

  1. ras Mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer

    Journal of Clinical Oncology, Vol. 21, Núm. 17, pp. 3226-3235

2002

  1. RET activation and clinicopathologic features in poorly differentiated thyroid tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 1, pp. 370-379

2000

  1. Single-unit recordings of arterial chemoreceptors from mouse petrosal ganglia in vitro

    Journal of Applied Physiology, Vol. 88, Núm. 4, pp. 1489-1495

1999

  1. Downregulation of p27(KIP1) and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories

    American Journal of Surgical Pathology, Vol. 23, Núm. 6, pp. 678-685

  2. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hurthle cell) neoplasms detected by comparative genomic hybridization

    Laboratory Investigation, Vol. 79, Núm. 5, pp. 547-555

  3. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma

    Cancer Research, Vol. 59, Núm. 8, pp. 1811-1815